Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 9;13(6):1335.
doi: 10.3390/microorganisms13061335.

Using Postbiotics from Functional Foods for Managing Colorectal Cancer: Mechanisms, Sources, Therapeutic Potential, and Clinical Perspectives

Affiliations
Review

Using Postbiotics from Functional Foods for Managing Colorectal Cancer: Mechanisms, Sources, Therapeutic Potential, and Clinical Perspectives

Teresa D'Amore et al. Microorganisms. .

Abstract

Postbiotics, defined as a preparation of inanimate microorganisms and/or their components, including metabolic byproducts, have gained recognition as promising modulators of gut health and disease, offering advantages over probiotics in terms of safety, stability, and formulation. This systematic review investigates the therapeutic potential of postbiotics derived from functional foods in the context of colorectal cancer (CRC), a leading cause of cancer-related mortality worldwide. Despite encouraging preclinical findings, translation into clinical practice remains limited due to a paucity of robust human trials, revealing a significant gap and the need for further translational research. Key bioactive categories of postbiotics are described, alongside their anti-inflammatory, immunomodulatory, and chemopreventive mechanisms. Through comprehensive literature mapping, this review uniquely categorizes research according to the experimental models employed, i.e., in vitro, in silico, in vivo, and ex vivo, and advanced models such as organoids and organ-on-chip platforms. The latter offers greater physiological relevance by closely mimicking human tissue architecture and microenvironment. These models help demonstrate how postbiotics may influence tumorigenesis through mechanisms involving inflammation, apoptosis, epigenetic regulation, and the maintenance of gut barrier integrity. Finally, the review summarizes recent innovations in their delivery strategies and calls for comprehensive mechanistic studies and high-quality clinical trials to validate postbiotics as safe and effective adjuncts in CRC prevention, therapy, and management.

Keywords: advanced preclinical models; carcinogenesis; chemoprevention; colorectal cancer; disease modelling; functional food; postbiotics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Trends of scientific publications on postbiotics over the last decade (2015–2024), based on data extracted from PubMed, Scopus, and Web of Science. The figure reflects the increasing number of studies focused on postbiotics, highlighting the growing interest and recognition of their therapeutic potential, especially in areas such as gut health, inflammation, and cancer.
Figure 2
Figure 2
Postbiotic bioactive metabolites.
Figure 3
Figure 3
Postbiotics from functional foods: key mechanisms of action for prevention and management of colorectal cancer.
Figure 4
Figure 4
Flow diagram of the extensive literature search for studies on postbiotics and colorectal cancer.

Similar articles

References

    1. Hou K., Wu Z.-X., Chen X.-Y., Wang J.-Q., Zhang D., Xiao C., Zhu D., Koya J.B., Wei L., Li J., et al. Microbiota in Health and Diseases. Signal Transduct. Target. Ther. 2022;7:135. doi: 10.1038/s41392-022-00974-4. - DOI - PMC - PubMed
    1. Zhao L.-Y., Mei J.-X., Yu G., Lei L., Zhang W.-H., Liu K., Chen X.-L., Kołat D., Yang K., Hu J.-K. Role of the Gut Microbiota in Anticancer Therapy: From Molecular Mechanisms to Clinical Applications. Signal Transduct. Target. Ther. 2023;8:201. doi: 10.1038/s41392-023-01406-7. - DOI - PMC - PubMed
    1. Fong W., Li Q., Yu J. Gut Microbiota Modulation: A Novel Strategy for Prevention and Treatment of Colorectal Cancer. Oncogene. 2020;39:4925–4943. doi: 10.1038/s41388-020-1341-1. - DOI - PMC - PubMed
    1. Vivarelli S., Salemi R., Candido S., Falzone L., Santagati M., Stefani S., Torino F., Banna G.L., Tonini G., Libra M. Gut Microbiota and Cancer: From Pathogenesis to Therapy. Cancers. 2019;11:38. doi: 10.3390/cancers11010038. - DOI - PMC - PubMed
    1. Murgiano M., Bartocci B., Puca P., di Vincenzo F., Del Gaudio A., Papa A., Cammarota G., Gasbarrini A., Scaldaferri F., Lopetuso L.R. Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools. Int. J. Mol. Sci. 2025;26:3059. doi: 10.3390/ijms26073059. - DOI - PMC - PubMed

LinkOut - more resources